U.K. hospital uses RapidArc on tongue cancer patient

Michael Bassett | | Health Imaging | Oncology Imaging
Ipswich Hospital in Ipswich, England, has carried out an image-guided intensity modulated radiotherapy (IMRT) procedure using Varian Medical Systems' RapidArc on a patient with tongue cancer.

The provider carried out the treatment on a 66-year-old male tongue cancer patient. According to Varian, before the deployment of RapidArc, the patient would have received treatment through a nine-field IMRT procedure that would have been longer than the radiotherapy treatment.

RapidArc delivers a volumetric intensity-modulated radiation therapy treatment in a single or multiple arcs of the treatment machine around the patient, said the Palo Alto, Calif.-headquartered company.
 

Michael Bassett,

Contributor

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.